227 related articles for article (PubMed ID: 12879463)
21. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M
Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708
[TBL] [Abstract][Full Text] [Related]
22. [Immunohistochemical detection and prognostic significance of p53 in the primary tumor of breast carcinoma patients].
Beck T; Weller E; Weikel W; Brumm C; Wilkens C; Knapstein PG
Geburtshilfe Frauenheilkd; 1995 May; 55(5):252-7. PubMed ID: 7607381
[TBL] [Abstract][Full Text] [Related]
23. Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer.
Murphy LC; Hilsenbeck SG; Dotzlaw H; Fuqua SA
Clin Cancer Res; 1995 Feb; 1(2):155-9. PubMed ID: 9815968
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of chorionic gonadotropin beta gene transcripts in human breast carcinoma.
Bièche I; Lazar V; Noguès C; Poynard T; Giovangrandi Y; Bellet D; Lidereau R; Vidaud M
Clin Cancer Res; 1998 Mar; 4(3):671-6. PubMed ID: 9533536
[TBL] [Abstract][Full Text] [Related]
25. Predictive value of c-erbB-2 and cathepsin-D for Greek breast cancer patients using univariate and multivariate analysis.
Scorilas A; Yotis J; Pateras C; Trangas T; Talieri M
Clin Cancer Res; 1999 Apr; 5(4):815-21. PubMed ID: 10213217
[TBL] [Abstract][Full Text] [Related]
26. A prognostic value of syndecan-1 in gastric cancer.
Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
Anticancer Res; 2000; 20(6D):4905-7. PubMed ID: 11326638
[TBL] [Abstract][Full Text] [Related]
27. Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype.
Carmeci C; Thompson DA; Kuang WW; Lightdale N; Furthmayr H; Weigel RJ
Surgery; 1998 Aug; 124(2):211-7. PubMed ID: 9706140
[TBL] [Abstract][Full Text] [Related]
28. Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis.
Scorilas A; Trangas T; Yotis J; Pateras C; Talieri M
Br J Cancer; 1999 Dec; 81(8):1385-91. PubMed ID: 10604737
[TBL] [Abstract][Full Text] [Related]
29. Expression of the cell-surface heparan sulfate proteoglycan mRNA in monkey submandibular gland.
Yamagata E; Kamada A
J Osaka Dent Univ; 1999 Oct; 33(2):83-7. PubMed ID: 10863479
[TBL] [Abstract][Full Text] [Related]
30. p53 and c-erbB-2 as markers of resistance to adjuvant chemotherapy in breast cancer.
Têtu B; Brisson J; Plante V; Bernard P
Mod Pathol; 1998 Sep; 11(9):823-30. PubMed ID: 9758361
[TBL] [Abstract][Full Text] [Related]
31. Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors.
Fujiwara H; Tortolero-Luna G; Mitchell MF; Koulos JP; Wright TC
Cancer; 1997 Feb; 79(3):505-12. PubMed ID: 9028361
[TBL] [Abstract][Full Text] [Related]
32. [Role of biological indicators in the therapeutic decision in breast carcinoma].
Amadori D; Maltoni R
Chir Ital; 1995; 47(4):15-22. PubMed ID: 9005127
[TBL] [Abstract][Full Text] [Related]
33. Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival.
Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma VM; Syrjänen K
Anticancer Res; 1995; 15(3):959-64. PubMed ID: 7645986
[TBL] [Abstract][Full Text] [Related]
34. Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome.
Kumar-Singh S; Jacobs W; Dhaene K; Weyn B; Bogers J; Weyler J; Van Marck E
J Pathol; 1998 Nov; 186(3):300-5. PubMed ID: 10211120
[TBL] [Abstract][Full Text] [Related]
35. Surfactant protein A expression in human normal and neoplastic breast epithelium.
Braidotti P; Cigala C; Graziani D; Del Curto B; Dessy E; Coggi G; Bosari S; Pietra GG
Am J Clin Pathol; 2001 Nov; 116(5):721-8. PubMed ID: 11710690
[TBL] [Abstract][Full Text] [Related]
36. Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas.
Puglisi F; Barbone F; Tell G; Aprile G; Pertoldi B; Raiti C; Kelley MR; Damante G; Sobrero A; Beltrami CA; Di Loreto C
Oncol Rep; 2002; 9(1):11-7. PubMed ID: 11748448
[TBL] [Abstract][Full Text] [Related]
37. Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype.
Contreras HR; Fabre M; Granés F; Casaroli-Marano R; Rocamora N; Herreros AG; Reina M; Vilaró S
Biochem Biophys Res Commun; 2001 Aug; 286(4):742-51. PubMed ID: 11520060
[TBL] [Abstract][Full Text] [Related]
38. Search for genes responsible for UV susceptibility of human cells: involvement of syndecan-1 in UV resistance.
Kikuno K; Kita K; Nomura J; Hiwasa T; Yonemitsu H; Suzuki N
Biochem Biophys Res Commun; 1998 Dec; 253(2):519-23. PubMed ID: 9878568
[TBL] [Abstract][Full Text] [Related]
39. [The effect of estrogen receptor level on the prognosis of the elderly breast cancer patients].
Xing BC; He L; Wang Y
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):365-7. PubMed ID: 10920918
[TBL] [Abstract][Full Text] [Related]
40. Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer.
Fujiya M; Watari J; Ashida T; Honda M; Tanabe H; Fujiki T; Saitoh Y; Kohgo Y
Jpn J Cancer Res; 2001 Oct; 92(10):1074-81. PubMed ID: 11676858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
